Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus [Phase 2]

View source ↗

Summary

A Phase 2 study assessed safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of GSK2330672 in adults with primary biliary cholangitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis
• Cholestasis

Drugs mentioned

• GSK2330672

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cholestasis, Intrahepatic | Phase 2 | Status: COMPLETED